Discovery of key mechanism could combat lenalidomide resistance in multiple myeloma

by

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance in multiple myeloma (MM), offering new insights into potential strategies for improving treatment outcomes and overcoming drug resistance.

Leave A Comment

Your email address will not be published. Required fields are marked *